---
title: Flamma vs J-STAR Research, Inc.
slug_a: flammagroup
slug_b: jstar-research
site: cdmo
review_signal_gate: closed
canonical_path: /compare/flammagroup/jstar-research
generated_by: BioBM Editorial AI
---

# Flamma vs J-STAR Research, Inc.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Flamma (flammagroup) is listed for cdmo. Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.

Services: 9. Modalities: 1. Indications: 0. Locations: 7. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

J-STAR Research, Inc. (jstar-research) is listed for cdmo. Contract process R&D and cGMP manufacturing for small molecule pharmaceuticals, specializing in high-potent compounds, controlled substances, crystallization development, and analytical services across Phase 1–3 clinical programs.

Services: 10. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.